Literature DB >> 12673425

Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.

Yoshiya Fujimoto1, Yukihiro Nakanishi, Kimio Yoshimura, Tadakazu Shimoda.   

Abstract

BACKGROUND: Malignant gastrointestinal stromal tumors (GISTs), previously termed leiomyosarcomas or epithelioid leiomyosarcomas, are known to show wide variability in their malignancy. We evaluated the clinicopathological features of a large number of primary malignant gastric GISTs to clarify which features were independent prognostic factors.
METHODS: Clinicopathologic features (age, sex, tumor location, mode of growth and size, surgical method, ulceration, cell type, nuclear atypia, cellularity, mitotic index, growth pattern, necrosis, hemorrhage, direct tumor invasion, peripheral lymphoid cuffing, expression of alpha-smooth muscle actin [alpha-SMA], desmin, caldesmon, vimentin, CD34, c-kit protein and s-100 protein, and MIB-1 index) were evaluated by multivariate analysis in 140 patients with resected primary malignant gastric GISTs identify independent prognostic factors.
RESULTS: Univariate analysis showed that each of the following factors had a significant deleterious influence on prognosis: male sex, tumor size 10 cm or more, presence of ulceration, an epithelioid cell component, severe nuclear atypia, high cellularity, a mitotic index of more than 10, an exogastric or invasive growth pattern, necrosis, hemorrhage, direct tumor invasion of surrounding tissue, negative caldesmon immunoreactivity, positive S-100 protein immunoreactivity, and a MIB-1 antigen labeling index of more than 10%. multivariate analysis showed that male sex, tumor size 10 cm or more, presence of an epithelioid cell component, and a mitotic index of more than 10 were statistically significant indicators of a poor prognosis ( P = 0.013, 0.001, 0.014, and <0.001, respectively). Multivariate analysis using the MIB-1 index instead of a mitotic count showed that male sex, tumor size 10 cm or more, presence of necrosis, and a MIB-1 antigen labeling index of more than 10% were independent predictors of a poor prognosis ( P = 0.009, 0.001, 0.043, and <0.001, respectively).
CONCLUSION: Male sex, tumor size 10 cm or more, and cell proliferation as estimated by the mitotic index or MIB-1 index are independent indicators of a poor prognosis in primary malignant gastric GIST.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673425     DOI: 10.1007/s101200300005

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  56 in total

1.  Advances in the surgical management of gastrointestinal stromal tumor.

Authors:  Umer I Chaudhry; Ronald P DeMatteo
Journal:  Adv Surg       Date:  2011

Review 2.  Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.

Authors:  Robert J Coffey; Mary Kay Washington; Christopher L Corless; Michael C Heinrich
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Laparoscopic resection of gastrointestinal stromal tumors: not all tumors are created equal.

Authors:  E L R Bédard; J Mamazza; C M Schlachta; E C Poulin
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

Review 4.  Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review.

Authors:  Fausto Catena; Monica Di Battista; Pietro Fusaroli; Luca Ansaloni; Valerio Di Scioscio; Donatella Santini; Maria Pantaleo; Guido Biasco; Giancarlo Caletti; Antonio Pinna
Journal:  J Gastrointest Surg       Date:  2007-11-27       Impact factor: 3.452

5.  Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience.

Authors:  Yoshinari Mochizuki; Yasuhiro Kodera; Michitaka Fujiwara; Seiji Ito; Yoshitaka Yamamura; Akira Sawaki; Kenji Yamao; Tomoyuki Kato
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 6.  How I do it: surgical management of gastrointestinal stromal tumors.

Authors:  Chandrajit P Raut; Stanley W Ashley
Journal:  J Gastrointest Surg       Date:  2008-03-04       Impact factor: 3.452

7.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

8.  Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Authors:  Haluk R Unalp; Hayrullah Derici; Erdinc Kamer; Ali D Bozdag; Ercument Tarcan; Mehmet A Onal
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.

Authors:  Halil Ozgüç; Tuncay Yilmazlar; Omer Yerci; Rusen Soylu; Volkan Tümay; Gülaydan Filiz; Abdullah Zorluoglu
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

10.  Clinicopathological study of 113 gastrointestinal stromal tumors.

Authors:  Rahul Bhalgami; Kak Manish; Prachi Patil; Shaesta Mehta; K M Mohandas
Journal:  Indian J Gastroenterol       Date:  2012-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.